- Home
- BNKKW vs CODX Comparison
BNKKW vs CODX Comparison
Compare BNKKW & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNKKW
- CODX
- Stock Information
- Founded
- BNKKW N/A
- CODX 2013
- Country
- BNKKW United States
- CODX United States
- Employees
- BNKKW N/A
- CODX N/A
- Industry
- BNKKW Package Goods/Cosmetics
- CODX Medical/Dental Instruments
- Sector
- BNKKW Consumer Discretionary
- CODX Health Care
- Exchange
- BNKKW Nasdaq
- CODX Nasdaq
- Market Cap
- BNKKW 16.9M
- CODX 15.6M
- IPO Year
- BNKKW 2020
- CODX 2017
- Fundamental
- Price
- BNKKW $0.08
- CODX $0.33
- Analyst Decision
- BNKKW
- CODX Buy
- Analyst Count
- BNKKW 0
- CODX 2
- Target Price
- BNKKW N/A
- CODX $2.00
- AVG Volume (30 Days)
- BNKKW N/A
- CODX 1.2M
- Earning Date
- BNKKW N/A
- CODX 11-06-2025
- Dividend Yield
- BNKKW N/A
- CODX N/A
- EPS Growth
- BNKKW N/A
- CODX N/A
- EPS
- BNKKW N/A
- CODX N/A
- Revenue
- BNKKW N/A
- CODX $1,003,653.00
- Revenue This Year
- BNKKW N/A
- CODX N/A
- Revenue Next Year
- BNKKW N/A
- CODX $31.58
- P/E Ratio
- BNKKW N/A
- CODX N/A
- Revenue Growth
- BNKKW N/A
- CODX N/A
- 52 Week Low
- BNKKW N/A
- CODX $0.23
- 52 Week High
- BNKKW N/A
- CODX $1.29
- Technical
- Relative Strength Index (RSI)
- BNKKW N/A
- CODX 44.29
- Support Level
- BNKKW N/A
- CODX $0.31
- Resistance Level
- BNKKW N/A
- CODX $0.36
- Average True Range (ATR)
- BNKKW 0.00
- CODX 0.04
- MACD
- BNKKW 0.00
- CODX -0.01
- Stochastic Oscillator
- BNKKW 0.00
- CODX 15.72
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.